Area of research
Cancer Research · Pulmonary and Respiratory Medicine
Research interest
Research focused on Cancer research and Mesenchymal stem cell, with related work in Microvesicles, Exosome, Bone marrow. Notable publications include 'Paclitaxel‑resistant gastric cancer MGC‑803 cells promote epithelial‑to‑mesenchymal transition and chemoresistance in paclitaxel‑sensitive cells via exosomal delivery of miR‑155‑5p', 'Lymph node metastasis-derived gastric cancer cells educate bone marrow-derived mesenchymal stem cells via YAP signaling activation by exosomal Wnt5a', and 'miR‐188‐5p suppresses cellular proliferation and migration via IL6ST: A potential noninvasive diagnostic biomarker for breast cancer'.
Rechallenge of immune checkpoint inhibitors in advanced non‐small cell lung cancer
The potential role of tumor deposits in the prognosis and TNM staging for colorectal cancer
Prognostic Significance of Methyl-CpG Binding Domain4 Polymorphism rs140693 and Clinical Characteristics in Chinese Lung Cancer Patients
Epidemiology, Prevention, and Treatment of Chemotherapy-Induced Myelosuppression in China: A National Cross-Sectional Study
Lactate induced mesenchymal stem cells activation promotes gastric cancer cells migration and proliferation
Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of YK-029A in Treatment-Naive Patients With Advanced NSCLC Harboring EGFR Exon 20 Insertion Mutations: A Phase 1 Trial
Clinical definition of secondary resistance to immunotherapy in non‐small cell lung cancer
A case report: A new promising treatment for pulmonary sarcomatoid carcinoma - Tislelizumab and Anlotinib combined with local radiotherapy
Exosomal CD44 Transmits Lymph Node Metastatic Capacity Between Gastric Cancer Cells via YAP-CPT1A-Mediated FAO Reprogramming
Gastric cancer-derived exosomes induce PD-L1 expression on human bone marrow mesenchymal stem cells through the AKT-c-Myc signal axis
A Prognostic Risk Model of a Novel Oxidative Stress‐Related Signature Predicts Clinical Prognosis and Demonstrates Immune Relevancy in Lung Adenocarcinoma
Analysis of adverse drug reactions of Osimertinib in the 2nd‐line treatment of <scp>EGFR</scp> mutant advanced nonsmall cell lung cancer
Lymph node metastasis-derived gastric cancer cells educate bone marrow-derived mesenchymal stem cells via YAP signaling activation by exosomal Wnt5a
LncRNA Snhg6 regulates the differentiation of MDSCs by regulating the ubiquitination of EZH2
G6PD-NF-κB-HGF Signal in Gastric Cancer-Associated Mesenchymal Stem Cells Promotes the Proliferation and Metastasis of Gastric Cancer Cells by Upregulating the Expression of HK2
Gastric Cancer Mesenchymal Stem Cells Inhibit NK Cell Function through mTOR Signalling to Promote Tumour Growth
Tumor Microenvironment Status Predicts the Efficacy of Postoperative Chemotherapy or Radiochemotherapy in Resected Gastric Cancer
Correction: MLKL promotes cellular differentiation in myeloid leukemia by facilitating the release of G-CSF
<p>Effectiveness and Safety of Apatinib in Patients with Advanced or Metastatic Adenocarcinoma of Stomach or Gastroesophageal Junction: A Prospective Observation Study</p>
miR‐188‐5p suppresses cellular proliferation and migration via IL6ST: A potential noninvasive diagnostic biomarker for breast cancer
Paclitaxel‑resistant gastric cancer MGC‑803 cells promote epithelial‑to‑mesenchymal transition and chemoresistance in paclitaxel‑sensitive cells via exosomal delivery of miR‑155‑5p
The role of mmu‐miR‐155‐5p‐<scp>NF</scp>‐<i>κ</i>B signaling in the education of bone marrow‐derived mesenchymal stem cells by gastric cancer cells
Human Gastric Cancer Mesenchymal Stem Cell-Derived IL15 Contributes to Tumor Cell Epithelial-Mesenchymal Transition via Upregulation Tregs Ratio and PD-1 Expression in CD4 <sup>+</sup> T Cell
Platelets enhance the ability of bone-marrow mesenchymal stem cells to promote cancer metastasis
Human Bone Marrow Mesenchymal Stem Cells Promote Gastric Cancer Growth via Regulating <i>c-Myc</i>